Product Images Hydroxyprogesterone Caproate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Hydroxyprogesterone Caproate NDC 47335-037 by Sun Pharmaceutical Industries, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
spl-hydroxyprogesterone-caproate-figure-1 - spl hydroxyprogesterone caproate figure 1
This appears to be a graph of the proportion of women who remain pregnant as a function of gestational age with hydroxyprogesterone caproate and control groups. The gestational age (in weeks) is plotted on the X-axis and the proportion of women remaining pregnant is shown on the Y-axis. There are two lines on the graph, one for the group given hydroxyprogesterone caproate and the other for the control group. The number at risk for each group is also shown.*
spl-hydroxyprogesterone-caproate-showbox - spl hydroxyprogesterone caproate showbox
This appears to be a description of a medication called Hydroxyprogesterone Caproate Injection, containing 250mg of Hydroxyprogesterone caproate USP, benzyl benzoate 46%, castor oil 28.6%, and benzy alcohol 2%, used for intramuscular administration. This medication is stored at 20 to 25°C and is intended for use within 5 weeks after first use. Full prescribing and patient information can be found in the package insert. The medication is distributed by Sun Pharmaceutical Industries, Inc. and is manufactured in India. There is an illegible section with some batch and expiration information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.